SAAD MUZAFFAR AZEEM et al. OPTIMIZING AMINOGLYCOSIDE DOSING IN CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE PATIENTS UNDERGOING INTERMITTENT HEMODIALYSIS: CARDIOVASCULAR IMPLICATIONS AND CLINICAL OUTCOMES. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 33, n. 2, p. 1139–1149, 2026. DOI: 10.69980/bn50yg38. Disponível em: https://jptcp.com/index.php/jptcp/article/view/13749. Acesso em: 5 oct. 2026.